Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga06-10

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Monday.

Shares of Perion Network Ltd. (NASDAQ:PERI) fell sharply in today's pre-market trading after the company lowered its revenue forecast.

Perion Network slashed its second-quarter revenue forecast from $118 million – $122 million to $106 million – $108 million. The company lowered its FY24 revenue forecast from $590 million – $610 million to $490 million – $510 million.

Perion Network shares dipped 21% to $9.74 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

  • Skye Bioscience, Inc. (NASDAQ:SKYE) shares tumbled 45.2% to $6.00 in pre-market trading as the company said its Phase 2a clinical trial of SBI-100 Ophthalmic Emulsion in patients with primary open-angle glaucoma or ocular hypertension did not meet its primary endpoint for lowering intraocular pressure.
  • CI&T Inc. (NYSE:CINT) shares declined 17.7% to $4.00 in pre-market trading.
  • Sify Technologies Limited (NASDAQ:SIFY) shares dipped 10.7% to $0.7413 in pre-market trading after the company announced intent to delist ADS Rights from the Nasdaq Capital Market.
  • Ecarx Holdings Inc. (NASDAQ:ECX) shares fell 9.2% to $0.98 in pre-market trading.
  • Alector Inc (NASDAQ:ALEC) shares declined 8.3% to $4.00 in pre-market trading.
  • TeraWulf Inc. (NASDAQ:WULF) shares fell 5.8% to $2.91 in pre-market trading after declining around 4% on Friday.
  • BW LPG Limited (NYSE:BWLP) shares fell 4.2% to $18.86 in pre-market trading.
  • Palantir Technologies Inc. (NYSE:PLTR) shares fell 3.6% to $22.48 in pre-market trading.
  • Rush Street Interactive, Inc. (NYSE:RSI) shares fell 3.4% to $8.60 in  pre-market trading.

Now Read This: Calavo Growers, Yext And 3 Stocks To Watch Heading Into Monday

Don't forget to check out our premarket coverage here

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment